CTOs on the Move

Occupational Environmental Health Solutions

www.oehsinc.com

 
Occupational Environmental Health Solutions is a Chatham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Sirius Medicine

Sirius Medicine is a Loveland, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stemtech Healthsciences

Stemtech Healthsciences is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Le-Vel

Premium Level: Premium Lifestyle Founded in 2012 by Jason Camper and Paul Gravette, Le-Vel formulates and sells nutritional/health and wellness products like the Le-Vel Thrive product line. Le-Vel is the only health and wellness company that uses cloud-based technology for its day-to-day business operations. Le-Vel`s cloud-based infrastructure enables the company to keep overhead to a minimum while increasing commissions and opportunities for its independent Brand Promoters and putting more money into the Le-Vel THRIVE product line. Some of the products in the Le-Vel line include: Thrive Premium Lifestyle DFT (Derma Fusion Technology), Thrive Premium Lifestyle Capsules, Thrive Premium Lifestyle Mix, Activate, Boost, Balance, Black Label, Café, DFT Duo, Expand, FORM, Thrive Kids, Move, Thrive PRO, Rest, Pure, BURN, THRIVEFIT and Thrive Bites. Le-Vel and the Le-Vel Thrive brand have more than 10 million customers and brand promoters. The company ships within the United States, Canada, Australia, New Zealand, the United Kingdom, and Mexico. In less than 7 years in business, Le-Vel reached $2 billion in lifetime sales.

Kidsvision

Kidsvision is a Jackson, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wave Life Sciences

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.